Legal Representation
Attorney
Virginia S. Medlen
USPTO Deadlines
Application History
26 events| Date | Code | Type | Description |
|---|---|---|---|
| Jul 3, 2006 | DOCK | D | ASSIGNED TO EXAMINER |
| Jul 3, 2006 | MAB3 | O | ABANDONMENT NOTICE MAILED - AFTER EX PARTE APPEAL |
| Jun 29, 2006 | EXPT | T | EXPARTE APPEAL TERMINATED |
| Jun 29, 2006 | ABN3 | O | ABANDONMENT - AFTER EX PARTE APPEAL |
| Mar 31, 2006 | EXPA | T | EX PARTE APPEAL-REFUSAL AFFIRMED |
| Sep 23, 2005 | CNES | W | SU - EXAMINER STATEMENT - WRITTEN |
| Sep 23, 2005 | CNES | O | EXAMINERS STATEMENT MAILED |
| Aug 10, 2005 | DOCK | D | ASSIGNED TO EXAMINER |
| Jul 25, 2005 | JURT | T | JURISDICTION RESTORED TO EXAMINING ATTORNEY |
| May 24, 2005 | EXAF | T | EXPARTE APPEAL RECEIVED AT TTAB |
| May 24, 2005 | EXPI | T | EX PARTE APPEAL-INSTITUTED |
| Nov 23, 2004 | CNFR | O | FINAL REFUSAL MAILED |
| Nov 22, 2004 | CNFR | W | SU - FINAL REFUSAL - WRITTEN |
| Sep 28, 2004 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Sep 3, 2004 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Sep 3, 2004 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Mar 12, 2004 | CNRT | F | NON-FINAL ACTION MAILED |
| Mar 10, 2004 | DOCK | D | ASSIGNED TO EXAMINER |
| Mar 9, 2004 | SUPC | I | STATEMENT OF USE PROCESSING COMPLETE |
| Feb 17, 2004 | EISU | I | TEAS STATEMENT OF USE RECEIVED |
| Feb 17, 2004 | IUAF | S | USE AMENDMENT FILED |
| Aug 26, 2003 | NOAM | O | NOA MAILED - SOU REQUIRED FROM APPLICANT |
| Jun 3, 2003 | PUBO | A | PUBLISHED FOR OPPOSITION |
| May 14, 2003 | NPUB | O | NOTICE OF PUBLICATION |
| Mar 10, 2003 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Mar 7, 2003 | DOCK | D | ASSIGNED TO EXAMINER |
Detailed Classifications
Class 005
Biopharmaceutical preparations used to treat cancer in humans, namely individualized cancer treatments prepared specifically for each individual patient from whom tumor tissue has been received
First Use Anywhere:
Jul 21, 2003
First Use in Commerce:
Sep 9, 2003
Classification
International Classes
005